pocketful logo light
pocketful logo light
Biocon Ltd logo

Biocon Ltd

NSE: BIOCON BSE: 532523

₹425.70

(0.08%)

Sat, 08 Aug 2026, 10:05 am

mtf coin illustrationMTF 5x

Biocon Share Price Live Chart

1 Day

(0.08%)

No Result Found

Summary

  • Market Cap (in Cr)

    69415.38

  • Net Profit (in Cr)

    1429.4

  • P/B

    1.89

  • Sector P/E

    33.76

  • P/E

    40.43

  • EV/EBITDA

    12.35

  • Debt/Equity (Industry)

    0.29

  • Interest Cover (Industry)

    4.50

  • ROCE (Industry)

    9.39

  • RONW (Industry)

    7.26

  • ROE

    6.90

  • ROCE

    6.86

  • Debt/Equity

    0.84

  • EPS (TTM)

    2.40

  • Dividend Yield

    0.12

  • Book Value

    209.95

  • Interest Cover

    3.10

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters44.9154.4554.4554.4560.64
FII7.527.396.616.045.66
DII24.0721.7122.1022.8215.72
Public23.4916.4516.8316.6817.97
Government00000

Read More

Technical Analysis

RSI

49.64

MACD

1.84

50 DMA

422.43

200 DMA

392.45

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic527.17474.87450.28422.57397.98370.27317.97
Fibonacci474.87454.89442.55422.57402.59390.25370.27
Camarilla440.08435.29430.49422.57420.91416.11411.32

Pivots Level: Classic

R3

+104.60

527.17

R2

+52.30

474.87

R1

+27.72

450.28

422.57
422.57
Pivot Point
LTP: 426.35

S1

-24.58

397.98

S2

-52.30

370.27

S3

-104.60

317.97

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    428.84

  • 20-EMA

    428.14

  • 30-EMA

    426.16

  • 50-EMA

    420.88

  • 100-EMA

    409.10

  • 200-EMA

    394.65

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
07 May 2026board-meetingsAccounts, Final Dividend
07 May 2026dividend₹0.50 Dividend /Share03 Jul 2026
12 Feb 2026board-meetingsQuarterly Results
06 Dec 2025egm
11 Nov 2025board-meetingsQuarterly Results
04 Jun 2025dividendFinal Dividend - Rs. - 0.504 Jul 2025
08 May 2025agm
08 May 2025dividend₹0.50 Dividend /Share04 Jul 2025
05 Jun 2024dividendFinal Dividend - Rs. - 0.505 Jul 2024
16 May 2024dividend₹0.50 Dividend /Share05 Jul 2024

Read More

Peer Comparison

Biocon Ltd logo

Biocon Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Read More

Biocon Ltd About

Biocon is engaged in the manufacture of biotechnology products and research services.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1978

Headquarters

CEO

Kiran Mazumdar Shaw

Employees

Contact

Website icon

Website

http://www.biocon.com

Email icon

Email

co.secretary@biocon.com

Phone icon

Phone

91-80-28082808

Location icon

Location

20th KM Hosur Road Hebbagodi, Electronic City P O, Bangalore, Karnataka, 560100

Read More

Biocon Ltd Company History

YearHistory
2021
  • Biocon launches Everolimus tablets in US.
  • Biocon enters out-licensing deal with Tabuk Pharmaceuticals.
  • Biocon Biologics’ interchangeable biosimilar Insulin Glargine preferred on Express Scripts’ US formulary.
  • Biocon enters Dow Jones Sustainability Emerging Markets Index.
  • Biocon partners with Tabuk Pharmaceuticals for speciality generics in Middle East.
2022
  • Biocon initiates clinical study of Itolizumab for Ulcerative Colitis in India.
  • Biocon Biologics completes acquisition of Viatris’ Global Biosimilars Business.
  • Biocon enters commercialization agreement with Zentiva in Europe.
  • Biocon ranks No. 8 in ‘Global Top Employers’ List by Science Magazine.
  • Biocon Foundation receives ‘Mahatma Award 2022 for Excellence in Social Good.
  • Biocon Sdn. Bhd. enters Malaysia Book of Records as largest integrated insulin facility.
2023
  • Biocon partners with Sandoz for Adalimumab BS distribution in Japan.
  • Biocon recognized as Asia IP Elite 2023; IPR Team named Team of the Year.
  • Biocon completes integration of Viatris’ Biosimilar Business in 31 European countries.
  • Biocon signs commercialization agreement with Juno Pharmaceuticals in Canada.
  • Biocon acquires manufacturing facility of Eywa Pharma Inc.
  • Biocon Biologics takes over commercialization of biosimilars from Viatris in 70+ emerging markets.
2024
  • Biocon ranked among Science Magazine’s Top 10 Global Employers.
  • Biocon Foundation honored with ‘Doing Good for Bharat Awards 2024’ in Healthcare Category for ‘eLAJ Smart Clinics’.
  • Biocon partners with Tabuk Pharmaceuticals to commercialize GLP-1 products in Middle East.
  • Biocon Foundation and IISc organize OCTF Conference on AI in Oral Cancer.
  • Biocon signs semi-exclusive distribution deal for generic Saxenda (Liraglutide) in Mexico.
2025
  • Biocon Biologics wins 'Data Privacy Program of the Year' at BW Tech World’s Tech Excellence Awards.
  • Biocon Biologics wins two awards at Asia Pacific Biopharma Excellence Awards (ABEA).
  • Biocon honored with Champion of CSR Award at ESG Impact Summit 2024.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
THE JUPITER GLOBAL FUND-JUPITER INDIA SELECTblockBuy469049279.818 Jan 2024
JUPITER SOUTH ASIA INVESTMENT COMPANY LIMITEDblockSell469049279.818 Jan 2024
AHAN - I LTDbulkSell18928363200.7417 Mar 2023
INTEGRATED CORE STRATEGIES (ASIA) PTE. LTD.bulkBuy8061599229.2628 Feb 2023
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell500049281.0514 Nov 2022
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy500049281.0514 Nov 2022
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell500049268.4503 Nov 2022
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy500049268.4503 Nov 2022
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell466252270.125 Oct 2022
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy466252270.125 Oct 2022

Read More

Biocon Ltd News

Biocon Gets Health Canada Nod for Yesintak Autoinjector

Biocon receives Health Canada approval for Yesintak (ustekinumab) autoinjector pen, expanding treatment options for autoimmune disease patients in Canada.

29 Jul 2026

companies

Biocon to announce Q1FY27 results on Aug 5

Biocon Limited will hold its board meeting on August 5, 2026, to approve un-audited financial results for the quarter ended June 30, 2026. An earnings call is scheduled for August 6.

28 Jul 2026

companies

Bobby Parikh ceases as Biocon Independent Director

Bobby Kanubhai Parikh ceased to be an Independent Director of Biocon Limited on July 22, 2026, following the completion of his second term. The Board acknowledged his contributions.

22 Jul 2026

companies

Biocon Schedules 48th AGM for August 6, 2026

Biocon Limited has announced its 48th AGM on August 6, 2026 via VC/OAVM, with e-voting from August 1–5, 2026. The company reported FY26 net profit of ₹3,856 million and recommended a final dividend of ₹0.50 per share.

15 Jul 2026

companies

Biocon Gets Mixed Signals from DAM Capital and Bernstein

DAM Capital maintains Buy on Biocon with ₹495 target, while Bernstein holds Underperform with ₹326 target, reflecting divergent views on biosimilars growth and leverage concerns.

15 Jul 2026

investment-ideas

Read More

Frequently Asked Questions

  • 1.What is the stock price of Biocon Ltd?

    As of 08/08/2026 at 3:35 PM, Biocon Ltd shares are trading at ₹425.70.

  • 2.What is the market cap. of Biocon Ltd?

    As of 08/08/2026, the market capitalization of Biocon Ltd is ₹69,300.83 crore.

  • 3.When was Biocon Ltd founded?

    Biocon Ltd was founded in 1978.

  • 4.What are the P/E and P/B ratios of Biocon Ltd?

    As of 08/08/2026, Biocon Ltd has a P/E ratio of 154.69 and a P/B ratio of 1.89.

  • 5.How can I buy shares of Biocon Ltd?

    You can buy shares of Biocon Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Biocon Ltd?

    As of March,2026, promoters hold 44.91% in Biocon Ltd, while FIIs, DIIs and public shareholders hold 7.52%, 24.07% and 23.49%, respectively.

  • 7.Does Biocon Ltd pay dividends?

    Yes, Biocon Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹0.50 Dividend /Share per share.

  • 8.What is the dividend yield of Biocon Ltd?

    As of 08 August, 2026, the dividend yield of Biocon Ltd stands at 0.12%.

  • 9.What are the latest financial results of Biocon Ltd?

    For January,2024, Biocon Ltd reported revenue of ₹15,211.00 crore and a net profit of ₹1,013.00 crore.

  • 10.What is the Stock symbol of Biocon Ltd?

    BIOCON is the stock symbol of Biocon Ltd.

  • 11.Who is the CEO of Biocon Ltd?

    The CEO of Biocon Ltd is Kiran Mazumdar Shaw.

Open Your Free Demat Account

Enter your phone number